-transparent.png){kind=logo}
The narcotic antagonist naloxone does not antagonize antinociception elicited in the rabbit by 100 microgram/kg of mescaline centrally administered, whereas pretreatment with 6-hydroxydopamine (6-OHDA) inhibits this mescaline effect. Stereotyped behavior of rabbits following central mescaline administration is also prevented by 6-hda pretreatment. Since 6-OHDA in known to produce a degeneration of catecholamine containing nerve terminals, a crucial role of catecholamines is suggested in the complex of effects seen in the rabbit after central administration of the hallucinogen.
Related Publications
S Ferri, and
R A Reina, and
P Braga
November 1972,
British journal of pharmacology,
S Ferri, and
R A Reina, and
P Braga
January 1974,
Pharmacology, biochemistry, and behavior,
S Ferri, and
R A Reina, and
P Braga
January 1984,
Journal of cardiovascular pharmacology,
S Ferri, and
R A Reina, and
P Braga
March 1986,
Il Farmaco; edizione scientifica,
S Ferri, and
R A Reina, and
P Braga
January 1985,
Peptides,
S Ferri, and
R A Reina, and
P Braga
March 1972,
Physiology & behavior,
S Ferri, and
R A Reina, and
P Braga
June 1976,
Psychopharmacology,
S Ferri, and
R A Reina, and
P Braga
September 2000,
Methods and findings in experimental and clinical pharmacology,
S Ferri, and
R A Reina, and
P Braga
January 1988,
The American journal of cardiovascular pathology,
S Ferri, and
R A Reina, and
P Braga
June 1971,
European journal of pharmacology,
